We are live on
!
Find out more
MS
Maven Securities Portfolio holdings
AUM
$5.2B
1-Year Est. Return
44.01%
This Fund
S&P 500
This Quarter
Est. Return
-20.08%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$3.29B
AUM Growth
+$417M
(+15%)
Cap. Flow
+$1.08B
Cap. Flow
% of AUM
32.97%
Top 10 Holdings %
Top 10 Hldgs %
41.34%
Holding
1,203
New
250
Increased
374
Reduced
203
Closed
334
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$60.7M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$60.3M |
| 3 |
Apple
AAPL
|
+$19.6M |
| 4 |
DOCU
DocuSign
DOCU
|
+$15.3M |
| 5 |
Adobe
ADBE
|
+$13.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APLS
Apellis Pharmaceuticals
APLS
|
+$11.2M |
| 2 |
COHR
Coherent Inc
COHR
|
+$11.2M |
| 3 |
JOBS
51job Inc
JOBS
|
+$9.34M |
| 4 |
Roku
ROKU
|
+$7.23M |
| 5 |
ADMA Biologics
ADMA
|
+$5.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.47% |
| 2 | Communication Services | 1.62% |
| 3 | Financials | 1.5% |
| 4 | Healthcare | 0.95% |
| 5 | Industrials | 0.95% |
Similar funds
AUB
AP
KACA
DDC
MIM
AAI
SDIC
SCM
Maven Securities's Q2 2022 Portfolio in Review
As of Q2 2022, Maven Securities held 1,203 positions worth $3.29B, up 15% from $2.87B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Maven Securities deployed $1.08B of net new capital in Q2 2022, opening 250 new positions and adding to 374 existing holdings. Its largest new stake was Apple: 129,157 shares worth $17.7M.
By sector, the portfolio is most concentrated in Technology at 3.5% of assets, up from 1.6% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was ADMA Biologics, an estimated $5.95M trimmed.
- Maven Securities's largest Q2 2022 buy was Apple: 129,157 shares worth $17.7M.
- Maven Securities added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $60.7M increase.
- Maven Securities's biggest Q2 2022 reduction was ADMA Biologics, cutting an estimated $5.95M.
- Maven Securities fully exited Apellis Pharmaceuticals in Q2 2022, selling an estimated $11.2M.
- Maven Securities's ten largest holdings make up 41% of its $3.29B portfolio in Q2 2022.
- Maven Securities opened 250 new positions and closed 334 in Q2 2022.
- Maven Securities's portfolio value rose 15% quarter-over-quarter to $3.29B.
Based on Maven Securities's 13F filing for Q2 2022, filed 15 Aug 2022.